MKN-74 Cells
| Unit |
3 x 10^6 cells/ml |
|---|---|
| Cell Type |
Tumor Cells |
| Tissue Type |
Gastric cancer cell lines |
| Organism |
Human |
| Donor History |
Gastric tubular adenocarcinoma |
| Growth Properties |
Adherent |
| Growth Conditions |
Culture medium: RPMI 1640 ,w: 2.0 mM stable Glutamine ,w: 2.0 g/L NaHCO3 (Cytion article number 820700a). Supplements: Supplement the medium with 10% FBS. Dissociation reagent: Accutase. Freeze medium: As a cryopreservation medium ,we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability ,or CM-1 (Cytion catalog number 800100) ,which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. Incubation atmosphere: 37°C ,5% CO2 ,humidified atmosphere. |
| Immortalization Method | |
| Full Information |
The MKN-74 cell line is derived from human gastric carcinoma and is part of the MKN series of cell lines, which were developed to study various aspects of gastric cancer. Specifically, MKN-74 was established from a poorly differentiated adenocarcinoma of the stomach, a type of gastric cancer known for its aggressive nature and poor prognosis. This cell line is particularly useful for research focused on understanding the molecular mechanisms driving tumor progression, invasion, and metastasis in poorly differentiated gastric cancers. MKN-74 cells exhibit an epithelial morphology and are known to grow in monolayers. They are characterized by their high proliferative capacity and ability to form colonies in soft agar, indicating a strong anchorage-independent growth potential, a hallmark of malignancy. This cell line is also valuable for studying the signaling pathways involved in gastric cancer, particularly those related to cell proliferation, survival, and resistance to chemotherapy. Additionally, MKN-74 cells have been used in xenograft models to investigate tumor growth and response to therapeutic agents, making them an important tool in preclinical drug development and cancer research.
Společnost Cytion vznikla v roce 2004 v německém Heidelbergu s jasným vědeckým posláním: dodávat ověřené lidské a zvířecí buněčné linie bez kontaminace, připravené za přísně kontrolovaných laboratorních podmínek.
Postupně se vypracovala ve spolehlivou buněčnou banku, která slouží akademickým laboratořím, biotechnologickým firmám i farmaceutickým výzkumným týmům po celém světě. Klade přitom důraz na reprodukovatelnost výsledků, přísnou kontrolu kvality a dlouhodobá partnerství.
Mikrobiologické aplikace
NGS
Rapid testy
PCR plasty
Třepačky
Suché lázně
Fluorometry
Buněčné kultury
PCR, qPCR, RT
Detekce Mycoplasmat
Reverzní transkripce
Alergie
Intolerance
Elisa
Imunologické analyzátory
Veterinární imunologie
Alergie u zvířat
Intolerance u zvířat
Čtečky identifikačních čipů
Termočipy
Biochemie
Imunoanalýza

